Kato, Koji http://orcid.org/0000-0002-5815-4585
Makita, Shinichi
Goto, Hideki
Kanda, Junya
Fujii, Nobuharu
Shimada, Kazuyuki
Akashi, Koichi
Izutsu, Koji
Teshima, Takanori
Fukuda, Natsuko
Sumitani, Tokuhito
Sumi, Hiroyuki
Shimizu, Shinji
Kakurai, Yasuyuki
Yoshikawa, Kenji
Tobinai, Kensei
Usui, Noriko
Hatake, Kiyohiko
Funding for this research was provided by:
daiichi-sankyo
Article History
Received: 30 June 2021
Accepted: 15 September 2021
First Online: 1 October 2021
Declarations
:
: KK reports honoraria from Kyowa Kirin, Takeda, and MSD, research funds from Celgene, Daiichi Sankyo, Novartis, and Chugai, and scholarship donations from Mundipharma. JK reports research funding from Eisai. KS reports research findings from Kyowa Kirin, Otsuka Pharmaceutical, and Bristol-Myers Squibb, and scholarship donations from Nippon Shinyaku, Zenyaku Kogyo, Chugai, Kyowa Kirin, Takeda, and Eisai. KA reports honoraria from Bristol-Myers Squibb, Celgene, Janssen, and Novartis and research funds from Daiichi Sankyo. KI reports honoraria from Celgene, Novartis, Daiichi Sankyo, and Chugai and research funding from Celgene, Novartis, Daiichi Sankyo, and Chugai. TT reports honoraria from Celgene, Novartis, Bristol Myers Squibb, Janssen, and Takeda, research funds from Daiichi Sankyo, Novartis, Takara Bio, Janssen, and Takeda, and scholarship donations from Takeda and Bristol Myers Squibb. SS and KY are employees of Daiichi-Sankyo and report profit from stock from Daiichi Sankyo. KT reports honoraria from Daiichi Sankyo, Celgene, Takeda, HUYA Bioscience, Zenyaku Kogyo, Yakult, Chugai, Mundipharma, Eisai, and Ono. NU reports honoraria from CMIC, AbbVie, Daiichi Sankyo, Nippon Shinyaku, Celgene, Pfizer, and Astellas. KH reports honoraria from Takeda, Daiichi Sankyo, Towa Pharmaceutical, Meiji Seika Pharma, and Celgene, manuscript fees from Takeda, and scholarship donations from Eisai and Takeda. NF, TS, HS, and YK are employees of Daiichi Sankyo. The other authors have no conflict of interest.